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Hypothalamic pituitary adrenal axisEstradiol (E2) plays an important role in controlling the homeostasis of body ﬂuids. Several studies have reported
the involvement of the hypothalamic pituitary adrenal axis (HPA) in the homeostatic control of hydromineral
balance and the inﬂuence of estrogens on themodulation of this system. Nevertheless, until now, the physiolog-
ical relevance of HPA axis activity on the hydromineral balance in females has not yet been fully elucidated.
Therefore, the objective of the present study was to evaluate the effects of E2 (20 μg/animal) pretreatment on
neuroendocrine and hydroelectrolyte changes induced by adrenalectomy (ADX) with or without glucocorticoid
hormone replacement (corticosterone, CORT; 10mg/kg) in ovariectomized rats (OVX). The results show that so-
dium appetite, natriuresis and the elevated plasma angiotensin II (ANG II) concentration induced by ADX were
attenuated by E2 pretreatment. Additionally, a reduction of AT1 mRNA expression in the subfornical organ
(SFO) and an increase in plasma atrial natriuretic peptide (ANP) concentrations by E2 pretreatment were ob-
served. E2 pretreatment reversed the reduction in water intake induced by ADX in ADX CORT-replaced rats.
Moreover, E2 pretreatment attenuated corticotropin releasing factor (CRF) mRNA expression in the
paraventricular nucleus (PVN) induced by ADX. In contrast, E2 pretreatment increased CRF mRNA expression
in the PVN in ADX CORT-replaced rats. Taken together, these results suggest that E2 has an important role in
the modulation of behavioral and neuroendocrine responses involved in the maintenance of body ﬂuid homeo-
stasis in ADX rats with or without glucocorticoid replacement therapy.
© 2013 Elsevier Inc. All rights reserved.Introduction
Appetite for sodium and thirst are important homeostatic behaviors
that contribute to the maintenance of body ﬂuid homeostasis. Adrenal
insufﬁciency induced by bilateral adrenalectomy (ADX) is known to
alter water and sodium balance due to the inability of the renal to
maintain sodium and water balance (Fitzsimons, 1998) in response to
an aldosterone deﬁcit (Krause and Sakai, 2007). Sodium depletion and
circulating volume reduction induce an increase in renin activation and,
consequently, an increase in the circulating levels of angiotensin II (ANG
II). ANG II mediates the dipsogenic and natriorexigenic responses elicited
by hypovolemic and hyponatremic stimuli (Fitzsimons, 1998), and these
ANG II effects have been postulated to be primarily mediated by its type
AT1 receptor (Beresford and Fitzsimons, 1992). Additionally, ANG II
exerts important renal effects such as antidiuresis and antinatriuresis,
which greatly contribute to the hydroelectrolyte balance (Hollenberg,
1984).
Several studies have investigated the involvement of thehypothalamic–
pituitary–adrenal (HPA) network in the control of body ﬂuid homeostasis.School of Medicine of Ribeirao
rigues).
ghts reserved.Experimental evidence shows that thirst and sodium appetite are stim-
ulated by systemic administration of adrenocorticotropic hormone
(ACTH; Li and Whitworth, 1992; Denton et al., 1999), whereas other
studies indicate that CRF also participates in the regulation of sodium
intake, but the mechanisms inﬂuenced by CRF in the control of sodium
appetite have not been elucidated (Watts, 1992).
Gonadal hormones, especially estrogen, play important roles in the
control of body ﬂuid homeostasis. It is well established in the literature
that estradiol (E2) regulates thirst and sodium appetite in females, al-
though the precise nature of their control has not been fully elucidated
(Covian and Antunes-Rodrigues, 1963; Danielsen and Buggy, 1980;
Jonklaas and Buggy, 1984; Fitzsimons, 1998). Additionally, E2 has an
important antinatriuretic effect, which induces an increase in renal
sodium tubular reabsorption (Brunette and Leclerc, 2001). The neuro-
endocrine control of the secretion of vasopressin (AVP), oxytocin (OT)
and atrial natriuretic peptide (ANP) is alsomodulated by estrogen. Sev-
eral studies have shown that E2 has a stimulatory effect on the secretion
of OT, ANP andAVP (Forsling et al., 1982; Jankowski et al., 2001;Mecawi
et al., 2011; Vilhena-Franco et al., 2011; Yamaguchi et al., 1979). The
secretion of AVP and OT occurs in response to osmotic, volemic and
non-osmotic stimuli (for review see Antunes-Rodrigues et al. (2004)).
In addition to its function in controlling blood pressure, ANP also plays
an important role in the control of hydromineral homeostasis, where
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1986; Quirion et al., 1988).
HPA axis activity is also inﬂuenced by gonadal steroids as illustrated
by the elevated plasma levels of glucocorticoids observed in females
(Critchlow et al., 1963; Kitay, 1961). In parallel with corticosterone
(CORT) hypersecretion, estradiol was shown to increase ACTH secretion
and mRNA expression of CRH in the PVN (Silva et al., 2010; Viau and
Meaney, 1991). However, other studies have shown that E2 decreases
or does not change the plasma levels of ACTH and CORT as well as
mRNAexpression of CRF in the PVN(Ferreira-Silva et al., 2009; Figueiredo
et al., 2002; Gerrits et al., 2005). In this context, the physiological rele-
vance of HPA axis activity related to the control of body ﬂuid homeostasis
aswell as themechanisms related to reproductive function in females are
not yet fully elucidated. Therefore, this study aims to elucidate the inﬂu-
ence of E2 and their interaction with corticosterone on behavioral,
endocrine and molecular changes involved in the control of body ﬂuid
homeostasis under adrenal insufﬁciency, using the experimental model
of adrenalectomywith or without glucocorticoid replacement in ovariec-
tomized rats.
Materials and methods
Animals
Female Wistar rats (~250g) obtained from the animal facility locat-
ed on the Campus of Ribeirao Preto, University of Sao Paulo, Brazil, were
maintained under controlled temperature (23±1°C) andwere exposed
to a daily 12:12h light–dark cycle (6:00 A.M.:6:00 P.M.)with free access
to tap water and pelleted food. All experimental procedures were per-
formed in the morning between 08:00 and 11:00 A.M. This study was
conducted according to the “Guide for the Care and Use of Laboratory
Animals” (NIH Publication No. 85-23, revised 1996), and the experi-
mental protocols were approved by the Ethical Committee for Animal
Use of the School of Medicine of Ribeirao Preto, University Sao Paulo
(protocol # 034/2010).
Surgeries
All surgeries were performed under anesthesia induced by 2,2,2-
tribromoethanol (250mg/kg, 2.5%, ip, Sigma Aldrich, St Louis, MO, USA),
followed by prophylactic doses of veterinary pentabiotic (Fort Dodge,
Campinas, SP, Brazil).
Ovariectomy and treatment with estradiol
Rats were subjected to bilateral ovariectomies (OVX) and randomly
separated into OVX groups treatedwith vehicle (corn oil, 0.2mL per rat,
subcutaneous) or OVX rats treated with estradiol cypionate (E2; Pﬁzer,
New York, NY, USA) at a dose of 20μg/animal, subcutaneous (OVX-E2).
The administration of vehicle or E2 began 24 h after surgery and was
conducted once a day for 14 days between 07:00 and 10:00 A.M. The
last administrations of estradiol or vehicle were performed 24h before
euthanasia. The efﬁciency of the surgical procedure and treatment
with E2 was conﬁrmed by body weight gain during the ﬁrst 7 days
and the uterine index at the end of the experiments (after 14 days).
On the seventh day of treatment with E2, the rats had a lower weight
gain compared to the OVX rats (21.62 ± 1.58 vs. 33.56 ± 2.14 g,
t(47)= 4.45, p b 0.001, n=24/25). At the end of the experiment, after
14 days of treatment with E2, the treatment increased the uterine
index of the animals (F7,93 = 737.89, df= 1, p b 0.001); however, the
uterine index was not affected by adrenalectomy or replacement with
corticosterone.
Adrenalectomy and corticosterone replacement
Seven days after treatment with E2 or vehicle, the OVX and OVX-E2
rats were submitted to bilateral adrenalectomies (ADX) or sham opera-
tions and randomly separated into groups treatedwith vehicle (corn oilin 5% ethanol, 0.2 mL per rat, sc, OVX-SHAM, OVX-E2-SHAM, OVX-
ADX, OVX-E2-ADX) or corticosterone (B; Sigma, St Louis, MO, USA)
at 10mg/kg, sc (OVX-SHAM-B, OVX-E2-SHAM-B, OVX-ADX-B, OVX-
E2-ADX-B). The administration began immediately after ADX sur-
gery and was conducted once a day for 7 days between 5:00 and
6:00 P.M. The last administrations of corticosterone or vehicle were
performed on the day before euthanasia. At the end of each study,
the success of the surgical procedure was veriﬁed by post-mortem
inspection to verify the absence of the adrenal glands. The last
administrations of vehicle, estradiol and corticosterone were per-
formed 24 h before euthanasia.
Water and sodium intake
Four days after treatment with E2 or vehicle, the animals were
placed in individual metabolic cages to appropriately adapt and were
providedwith two bottles per animal ﬁlledwith hypertonic saline solu-
tion (1.8% NaCl) or tap water, and they were provided with food ad lib.
Fluid intake was evaluated daily for 6 days following ADX. The ratio
of water to sodium intake was calculated as: (1.8% NaCl intake/water
intake+1.8% NaCl intake)×100 (Frankmann et al., 1991).
As bodyweight gain (Fig. 1C) varied signiﬁcantly in function of treat-
ments (oil vs. estradiol, F7,93 = 8.22, df = 1, p b 0.01; sham vs. ADX,
F7,93 = 8.77, df = 1, p b 0.01; between the three factors, F7,93 = 4.67,
df = 1, p b 0.05) the measures were analyzed both as absolute and as
body weight-adjusted values. The results for absolute and body
weight-adjusted measures did not show differences in the pattern of
response. Thus only the adjusted results are presented. Therefore, the
values are expressed as mL/100 g body weight. In addition, for better
visualization the data were presented in the ﬁgures as water and
sodium intakes accumulated during six days and are expressed as
mL/100g body weight/6days. Similarly, this procedure was performed
with the ratio of water to sodium intake analysis. Table 1 showed the
daily values of the analyzed responses.
Determination of urinary sodium
The urine samples were collected on days 1, 3, and 6 after ADX for
urinary sodium concentration determined by ﬂame photometry
(Flame Photometer, Micronal Model B-262, Sao Paulo, SP, Brazil). The
results are expressed as mEq/100g body weight. In addition, for better
visualization the data were presented in the ﬁgure as accumulated dur-
ing three days and are expressed as mL/100 g body weight/3 days.
Table 1 showed the daily values of the analyzed responses.
Determination of plasma sodium concentration and hematocrit
Plasma sodium concentrationwas analyzed using ﬂame photometry
(Micronal B-262, Sao Paulo, SP, Brazil). Plasma volume was indirectly
inferred from the hematocrit values that were determined using small
aliquots of trunk blood collected in capillary tubes and was expressed
as the percentage of cells in the blood. To determine these parameters,
the animals were decapitated on the fourteenth day of treatment with
estradiol or vehicle.
Blood collection, hormonal extractions and immunoassays
After fourteen days of E2 treatment or seven days of replacement
with CORT, the animals were decapitated, and their trunk blood was
collected for OT, AVP, ANG II, ANP and CORT analysis. Blood collection
was performed in chilled plastic tubes containing heparin (10 μL of
heparin per mL of blood) to measure plasma OT, AVP and CORT or
ethylenediaminetetraacetic acid (2mg/mL) and proteolytic enzyme in-
hibitors (10μL of 1mMphenylmethylsulfonyl ﬂuoride, 10μL of 500mM
pepstatin A and 20 μL of p-hydroxymercuribenzoate per mL of blood)
for plasma ANP and ANG II determination. Plasma was obtained after
Fig. 1. Effect of pretreatmentwith estradiol on thewater intake accumulated during 6days
(A) and on the sodium intake accumulated during 6 days (B) in OVX rats submitted to
adrenalectomy with or without replacement with CORT and CORT treatment in rats
with intact adrenal glands. The values are adjusted per 100 g of body weight (bw) and
expressed as means± SEM. Body weight gain 6 days after adrenalectomy (C). +p b 0.05
vs. respective OVX SHAM group, #p b 0.05 vs. respective OVX SHAM B group, Ψp b 0.05
vs. respective OVX ADX group, *p b 0.05 vs. respective OVX oil group. In graphic C
sample size (n) is represented inside the columns in graphic A.
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speciﬁc extraction and immunoassay procedures were initiated. AVP
andOTwere extracted from1mLof plasmawith acetone andpetroleum
ether, while CORT was extracted from 25 μL of plasma with 1 mL
ethanol, and ANP and ANG II were extracted from 1 mL of
plasma using Sep-Pak C-18 cartridges (Waters Corporation, Milford,
MA, USA).
All hormone measurements were performed using speciﬁc
radioimmunoassay techniques as previously described by Elias et al.
(1998), Haanwinckel et al. (1995), Gutkowska et al. (1984), Botelho
et al. (1994), and Vecsei (1979) for AVP, OT, ANP, ANG II and CORT,
respectively. All measurements were performed in duplicate in the
same assay. The sensitivity of the assay and the coefﬁcient of variation
intra-assay were 0.12 pg/mL, 10.6% for AVP; 0.12 pg/mL, 8.3% for OT;
0.7 pg/mL, 3.7% for ANP; and 0.4pg/mL, 9.4% for ANG II. The sensitivity
of the assay and the coefﬁcient of variation for the intra- and inter-
assays were 0.4 μg/dL and 8.0%–10.6% for CORT, respectively.Microdissection, RNA isolation and semi-quantitative real-time PCR
After fourteen days of treatment with E2 or seven days of replace-
ment with CORT, the animals were decapitated, their brains were
collected under RNAse-free conditions, and they were immediately fro-
zen on dry ice and stored at−80°C to determine CRFmRNA expression
in the PVN and AT1 receptor mRNA expression in the subfornical organ
(SFO). Tissue samples of the PVN and SFO were obtained by microdis-
section of coronal sections of 1800μm in cryostat, according to the coor-
dinates of the atlas (Paxinos andWatson, 1997):−0.7mm to−2.5mm,
in relation to the bregma. Samples of PVN and SFO were collected
through a 1.5 mm diameter sterile needle, transferred to a microtube
containing RNAlater reagent (Ambion, Austin, TX, USA), maintained
for approximately 12 h at 4 °C and then stored at −70 °C until RNA
extraction.
Total RNA was extracted using TRIzol Reagent (Invitrogen®,
Carlsbad, CA, USA) and quantiﬁed by UV spectrophotometry. The
synthesis of complementary DNA (cDNA) was performed using 500ng
of total RNA using the High-Capacity cDNA Reverse Transcription kit
(Applied Biosystems, Foster City, CA, USA). Quantitative real-time PCR
was performed using Applied Biosystems Step One Plus Real-Time PCR
System. The reactions were performed in triplicate, and water (instead
of cDNA) was used as negative control. The results were analyzed ac-
cording to the ΔΔCt method. β-Actin was used as the endogenous con-
trol (4352340E, Applied Biosystems). The Ct of β-actin was subtracted
from the Ct of the gene of interest (CRF, Rn 01462137_m1, AT1, Rn
00578456_m1, Applied Biosystems) to determine the ΔCt of each sam-
ple (ΔCt=Ctunknown−Ctreference gene). The ΔCt of the calibrator (control
groupOVX SHAM)was subtracted from theΔCt of each sample to deter-
mine the ΔΔCt (ΔΔCt=ΔCtunknown−ΔCtcalibrator). This value was used
in the equation 2−ΔΔCt, and the results represent the relative expression
of mRNA expressed in arbitrary units.
Statistical analysis
Results are presented as the mean ± standard error (SEM). Data
were analyzed using Statistica (StatSoft, USA) through the factorial
analysis of variance (three-way ANOVA) with the hormonal proﬁle
(E2 and B) and ADX surgery as independent variables. For the analyze
of the dependent variables: daily water and sodium intake, ratio of
water to sodium intake and natriuresis; with the hormonal proﬁle (E2
and B), ADX surgery and days as independent variables, it was per-
formed general linear models univariate (GLM) with days as random
factor (mixed-model). Post-hoc comparisons of Fisher's least-
signiﬁcant-difference test were performed only when the F value was
signiﬁcant, that is, when the test showed statistically signiﬁcant effects
and interactions. The level of signiﬁcance was set at 5% (α=5%).
Results
Effect of pretreatment with estradiol on sodium appetite, thirst and
natriuresis in OVX control rats and OVX rats submitted to ADX with or
without glucocorticoid replacement
Water intake (Table 1 and Fig. 1A) varied signiﬁcantly in function of
treatments (oil vs. estradiol, F7,93=8.54, df=1, pb0.01; sham vs. ADX,
F7,93=69.34, df=1, pb 0.001) but it was not inﬂuenced by treatment
with CORT. Signiﬁcant interactions were observed between the three
treatments (F7,93=8.42, df=1, pb0.01). The ADX induced a reduction
in water intake in both OVX animals (p b 0.01) and in OVX animals
treated with E2 (p b 0.01). However, E2 pretreatment increased water
intake in the ADX B groups compared to oil treatment (pb0.05).
In regard to salt intake, the results obtained indicate that the intake
of hypertonic saline (1.8% NaCl, Fig. 1B and Table 1) increased after ADX
(F7,93=303.17, df=1, p b 0.001), and replacement with CORT did not
reverse this effect. Furthermore, sodium intake also varied in function
Table 1
Daily water intake (mL/100 g body weight), sodium intake (mL/100 g body weight), ratio of water to sodium intake (%) and urinary sodium (mEq/100 g body weight) in OVX rats sub-
mitted to adrenalectomy with or without replacement with CORT and CORT treatment in rats with intact adrenal glands.
Oil Estradiol
SHAM SHAM B ADX ADX B SHAM SHAM B ADX ADX B
Water intake
Day 1 14.5± 1.0 16.3± 1.4 10.2± 1.0a 11.7± 1.2b 14.2± 1.2 13.1± 0.7 10.4± 0.9ª 12.6± 1.8
Day 2 17.0± 1.1 18.3± 1.8 12.4± 1.2a 11.7± 1.3ª,b 18.1± 1.1 16.8± 0.7 13.0± 0.6ª 15.1± 1.6
Day 3 15.7± 1.0 17.8± 1.7 11.8± 1.4a 12.2± 0.8ª,b 17.2± 1.0 16.5± 0.9 11.7± 0.9ª 14.4± 1.1
Day 4 13.0± 0.8 12.8± 1.2 10.1± 1.3 10.0± 0.5 14.0± 0.9 14.5± 1.1 11.4± 1.0 14.0± 1.4d
Day 5 15.9± 1.0 16.1± 1.7 11.2± 1.4a 11.5± 0.9ª,b 16.3± 0.9 15.6± 0.9 11.6± 1.1ª 14.7± 1.3
Day 6 10.8± 1.0 10.3± 2.2 10.0± 1.2 7.9± 1.0 12.5± 1.5 12.2± 0.7 9.7± 0.8 14.0± 2.0c,d
Sodium intake
Day 1 1.8± 0.5 3.2± 0.7 4.3± 0.8ª 4.1± 1.0a 1.8± 0.5 1.7± 0.3 3.9± 0.4 3.2± 0.5
Day 2 2.9± 0.5 4.6± 0.7 7.3± 0.7ª 7.0± 0.9a,b 2.3± 0.5 2.1± 0.4d 5.0± 0.8a,d 5.0± 0.8a,b
Day 3 1.7± 0.3 4.1± 1.0a 8.1± 0.4ª 6.0± 1.1a,c 1.1± 0.3 1.4± 0.3d 5.1± 1.1a,d 5.4± 0.9a,b
Day 4 1.9± 0.4 4.0± 0.8ª 9.2± 0.6ª 7.9± 1.0a,b 1.2± 0.3 1.4± 0.3d 5.4± 0.8a,d 7.2± 1.0a,b
Day 5 2.2± 0.5 4.6± 1.3ª 8.6± 0.5ª 8.6± 1.5ª,b 1.3± 0.5 1.9± 0.4d 5.7± 1.1a,d 7.1± 0.9a,b
Day 6 3.2± 0.7 5.3± 0.7ª 8.6± 0.7ª 9.5± 1.4ª,b 1.4± 0.6 1.9± 0.5d 6.2± 1.3a,d 7.1± 1.0a,b,d
Ratio S/TF intake
Day 1 10.3± 2.5 15.9± 3.4 29.7± 4.6a 25.2± 4.0a 9.6± 2.5 11.4± 2.2 27.5± 2.6ª 21.5± 3.0a
Day 2 15.1± 3.1 20.5± 3.6 36.4± 2.2a 39.6± 5.4ª,b 10.3± 1.9 10.8± 2.0 27.3± 3.4ª 23.8± 2.6ª,d
Day 3 10.1± 2.0 18.5± 3.7 41.7± 2.1a 32.3± 4.8ª,b,c 5.7± 1.7 7.7± 1.7d 28.0± 5.3ª,d 25.9± 3.6ª
Day 4 12.4± 2.6 24.0± 4.8a 48.2± 3.0a 43.9± 3.6ª,b 7.4± 2.1 9.1± 1.5d 32.4± 4.5ª,d 33.7± 3.9ª
Day 5 11.9± 2.5 21.7± 4.5 44.6± 2.8ª 41.6± 5.7ª,b 6.2± 1.9 11.1± 2.7d 32.2± 5.5ª,d 32.5± 2.9ª
Day 6 23.1± 4.0 40.0± 6.6a 48.5± 3.7ª 53.3± 5.2ª,b 9.7± 3.7d 12.7± 3.1d 36.2± 5.7ª,d 34.8± 3.9ª,d
Natriuresis
Day 1 0.64±0.3 0.45±0.1 1.12± 0.2 1.02± 0.2 0.26±0.09 0.26±0.07 0.59± 0.2 0.77±0.2
Day 3 0.70±0.2 1.10±0.3 2.11± 0.3a 2.05± 0.3ª,b 0.38±0.08 0.39±0.06d 1.32± 0.3ª,d 1.38±0.3ª,b,d
Day 6 1.25±0.4 1.44±0.2 2.70± 0.4a 2.55± 0.5ª,b 0.39±0.08d 0.41±0.08d 1.50± 0.3ª,d 1.03±0.2ª,d
Data are expressed asmeans±SEM. S/TF=sodium/total ﬂuid intake. (a) pb0.05 vs. respective Oil SHAMgroup, (b) pb0.05 vs. respective Oil SHAMB group, (c) pb0.05 vs. respective Oil
ADX group, and (d) p b 0.05 vs. respective Oil group. The sample size is presented in Fig. 1A.
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ated ADX-induced sodium intake. Only treatment with CORT in rats
with intact adrenal glands was capable of inducing increased sodium
intake (F7,93=6.27, df=1, p b 0.05), which was also attenuated by E2
pretreatment (pb0.01). Signiﬁcant interactionswere observed between
the three treatments (F7,93=11.21, df=1, pb0.001).
Adrenalectomy also induced an increase in the ratio ofwater to sodi-
um intake (F7,93=338.73, df=1, pb0.001, Table 1 and Fig. 2); however,
CORT replacement did not reverse this effect. By contrast, pretreatment
with E2 attenuated sodium appetite (F7,93 = 82.46, df = 1, p b 0.001)
in ADX rats with or without CORT replacement and in rats with intact
adrenal glands treated with CORT. Post-test analysis showed thatFig. 2.Effect of pretreatmentwith estradiol on the ratio ofwater to sodium intake accumu-
lated during 6days in OVX rats submitted to adrenalectomy with or without replacement
with CORT and CORT treatment in rats with intact adrenal glands. The values are
expressed as means ± SEM. +p b 0.05 vs. respective OVX SHAM group, #p b 0.05 vs.
respective OVX SHAM B group, *p b 0.05 vs. respective OVX oil group. The sample size
(n) is represented inside the columns.treatment with CORT in rats with intact adrenal glands induced an
increase in sodium appetite (pb0.05). Signiﬁcant interactions were ob-
served between the three treatments (F7,93=4.01, df=1, pb0.05).
Regarding urinary excretion of sodium (Fig. 3 and Table 1), ADX
induced a signiﬁcant increase in natriuresis in both the OVX group
and in the OVX group previously treated with E2 (F7,93 = 65.23,
df = 1, p b 0.001). These effects were not reversed by replacement
with CORT. However, E2 pretreatment reduced natriuresis irrespec-
tive to the presence (SHAM) or absence (ADX) of adrenal glands or
CORT treatment (F7,93= 46.13, df=1, p b 0.001). Urinary excretion
of sodium was not inﬂuenced by CORT replacement in ADX rats or
treatment with CORT in SHAM rats.Fig. 3. Effect of pretreatment with estradiol on the sodium urinary excretion accumulated
during 3 days in OVX rats submitted to adrenalectomy with or without replacement with
CORT and CORT treatment in rats with intact adrenal glands. The values are adjusted per
100 g of body weight (bw) and expressed as means ± SEM. +p b 0.05 vs. respective
OVX SHAM group, #p b 0.05 vs. respective OVX SHAM B group, Ψp b 0.05 vs. respective
OVX ADX group, *pb0.05 vs. respective OVX oil group. The sample size (n) is represented
inside the columns.
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hematocrit values in OVX control rats and OVX rats submitted to ADX with
or without glucocorticoid replacement
No signiﬁcant differences in plasma sodium concentration were
observed in any experimental conditions (Fig. 4A). Hematocrit varied
signiﬁcantly in function of pretreatment with E2 (F7,93=13.51, df=1,
p b 0.001) but it was not inﬂuenced by ADX or CORT replacement and
treatment with CORT in SHAM rats. The post-test analysis showed
that treatment with E2 reduced hematocrit in rats submitted to ADX
(pb0.05, Fig. 4B).
Effect of pretreatment with estradiol on the plasma levels of AVP, OT, ANP
and ANG II in OVX control rats and OVX rats submitted to ADX with or
without replacement of glucocorticoids
ADX induced a signiﬁcant increase in plasma levels of ANG II
(F7,81=160.51, df=1, pb0.001). Signiﬁcant interactionswere observed
between the three treatments (F7,81=16.45, df=1, pb0.001). Analysis
performed using the post-test indicated that pretreatment with E2
attenuated ADX-induced increase in plasma ANG II (pb0.001). Replace-
ment with CORT in ADX animals reduced the plasma levels of ANG II
rats (pb 0.001). However, OVX rats submitted to ADX, pretreated with
E2 and replaced with CORT (OVX E2 ADX B) had higher circulating
levels of ANG II, demonstrating a reversal of the effect induced by both
E2 and by CORT when these hormones were administered separately
(pb0.01, Fig. 5A).
The plasma concentration of ANP varied signiﬁcantly in function of
the treatments (oil vs. estradiol, F7,77=5.39, df=1, p b 0.05; sham vs.
ADX, F7,77 = 7.83, df = 1, p b 0.01; oil vs. CORT, F7,77 = 12.09, df = 1,
p b 0.001). As shown in Fig. 5B, ADX rats previously treated with E2
had higher plasma concentrations of ANP (p b 0.01); however, ADX
rats replaced with CORT and pretreated with E2 had lower levels of
ANP compared to ADX rats treated only with E2 (pb0.001).
Although OT secretion did not change in most of the experimental
conditions, the pretreatment with E2 in ADX B rats induced a reductionFig. 4. Effect of pretreatment with estradiol on the plasma sodium concentration (A) and
on the hematocrit (B) in OVX rats submitted to adrenalectomy with or without replace-
ment with CORT and CORT treatment in rats with intact adrenal glands. The values are
expressed as means ± SEM. *p b 0.05 vs. respective OVX oil group. The sample size (n)
is represented inside the columns in graphic A.in the plasma OT concentration (interaction between E2 vs. CORT,
F(7,90)=6.26, df=1, pb0.05). On the other hand, no signiﬁcant differ-
ences were observed in the plasma AVP concentrations in any experi-
mental condition studied (Fig. 5D).
Effect of pretreatment with estradiol on AT1 mRNA expression in the SFO
in OVX control rats and OVX rats submitted to ADX with or without
replacement of glucocorticoids
Pretreatment with E2 reduced the relative expression of AT1 mRNA
in the SFO of OVX rats with intact adrenal glands and in OVX ADX rats
(F7,56= 15.28, df = 1, p b 0.001), as shown in Fig. 6. By contrast, ADX
and replacement or treatment with CORT did not affect the relative
expression of AT1 mRNA in the SFO.
Effect of pretreatment with estradiol on CRF mRNA expression in the PVN
and plasma corticosterone levels in control OVX rats and OVX rats
submitted to ADX with or without replacement of glucocorticoids
The relative expression of CRFmRNA in the PVN (Fig. 7A) varied sig-
niﬁcantly in function of the treatments (sham vs. ADX, F7,55 = 54.33,
df=1, pb0.001; oil vs. CORT, F7,55=31.51, df=1, pb0.001). Moreover,
signiﬁcant interactions were observed among the three treatments
(F7,55 = 6.04, df = 1, p b 0.05). The results showed that ADX in OVX
rats induced an increase in CRF mRNA expression (p b 0.001) that was
signiﬁcantly attenuated by E2 pretreatment (p b 0.05). In addition, re-
placement with CORT decreased both CRF mRNA expression in ADX
(p b 0.001) and in E2-treated rats (p b 0.05). However, OVX E2 ADX B
rats showed a higher level of CRF mRNA expression compared to OVX
ADX B rats (pb0.01).
Regarding plasma CORT levels (Fig. 7B), they varied signiﬁcantly in
relation to the treatments (oil vs. estradiol, F7,79 = 75.66, df = 1,
p b 0.001; sham vs. ADX, F7,79 = 154.43, df = 1, p b 0.001), but they
were not inﬂuenced by treatment or CORT replacement. Signiﬁcant in-
teractions between the three factors were also observed (F7,79= 6.45,
df = 1, p b 0.01). Pretreatment with E2 induced an increase in plasma
levels of CORT in OVX rats with intact adrenal glands (p b 0.001). ADX
induced a reduction in CORT plasma concentration levels in both OVX
and OVX E2 rats (p b 0.01); however, replacement or treatment with
CORT at the dose used in our experimental model did not cause CORT
plasma levels to signiﬁcantly differ in OVX rats with intact adrenal
glands (OVX SHAM). Therefore, these results provide evidence that
validates ADX surgery and CORT therapy.
Discussion
In the present study, we observed that adrenalectomy induced a re-
duction in water intake, an increase in sodium intake and an increased
ratio of water to sodium intake in OVX rats. In addition, ADX leads to
an increase in renal sodium excretion and in body sodium depletion,
due to aldosterone deﬁciency (Fitzsimons, 1998; Krause and Sakai,
2007). This body sodiumdeﬁcit and consequent reduction in extracellu-
lar ﬂuid volume are detected by specialized receptors that convey this
information to speciﬁc areas of the central nervous system (CNS) such
as the circumventricular organs (CVO), which are responsible for an
integrated response and induce increased sodium appetite with subse-
quent restoration of circulating volume (Antunes-Rodrigues et al., 2004;
Fitzsimons, 1998). In fact, OVX ADX rats did not show a change in their
circulating volume seven days after ADX with free access to tap water
and hypertonic saline, which was indicated by the absence of changes
in hematocrit values in these animals. Thus, in response to seven days
of ADX with free access to water and hypertonic saline, an increase in
sodium and reduced water intake was observed, which maintains ade-
quate plasma osmolality (data not shown) and restores their circulating
volume. Because the spontaneous consumption of water is associated
with feeding, and ADX rats present a hypophagic response, possibly
Fig. 5. Effect of pretreatment with estradiol on the plasma levels of angiotensin II (A), atrial natriuretic peptide (B), oxytocin (C) and vasopressin (D) in OVX rats submitted to adrenalec-
tomywith orwithout replacementwith CORT and CORT treatment in ratswith intact adrenal glands. The values are expressed asmeans±SEM.+pb0.05 vs. respective OVX SHAMgroup,
#p b 0.05 vs. respective OVX SHAM B group,Ψp b 0.05 vs. respective OVX ADX group, *p b 0.05 vs. respective OVX oil group. The sample size (n) is represented inside the columns.
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reduction of food intake (Kraly, 2004; Uchoa et al., 2010).
ADX in OVX rats also induced an increase in plasma levels of ANG II,
which signiﬁcantly contributes to the stimulation of sodium appetite in
these animals. Sodium appetite in sodium-depleted ADX rats may be
mediated by peripheral ANG II via activation of AT1 receptors present
in the CVOs, primarily in the SFO and in the organum vasculosum of
the lamina terminalis (OVLT; Morris et al., 2002;Weisinger et al., 2000).
Conversely, pretreatment with E2 signiﬁcantly attenuated sodium
appetite, the elevated plasma levels of ANG II and themRNA expression
of the AT1 receptor in the SFO in response to ADX. Thus, E2 may atten-
uate sodium appetite in response to ADX by reducing circulating levels
of ANG II and reduction of central ANG II actions via down-regulation of
AT1 receptors in the SFO. These results corroborate data from the liter-
ature that demonstrates that E2 attenuates sodium appetite and thirst
in female rats during proestrus and OVX rats treated with E2 submitted
to dipsogenic and natriorexigenic challenges as well as in response to
ANG II central administration (Covian and Antunes-Rodrigues, 1963;Fig. 6. Effect of pretreatment with estradiol on the relative expression of AT1 receptor
mRNA in the SFO in OVX rats submitted to adrenalectomy with or without replacement
with CORT and CORT treatment in rats with intact adrenal glands. The values are
expressed as means ± SEM. *p b 0.05 vs. respective OVX oil group. The sample size (n)
is represented inside the columns.Danielsen and Buggy, 1980; Jonklaas and Buggy, 1984; Mecawi et al.,
2007, 2008; Stricker et al., 1991). Additionally, recent studies have
shown that treatment with E2 in OVX rats reduced the interaction
between ANG II and AT1 receptors in the SFO (Kisley et al., 1999) and
reduced neuronal activity in the OVLT and SFO during intracarotid
administration of ANG II (Tanaka et al., 2001).
Furthermore, the results showed that OVX E2 ADX rats had higher
circulating levels of ANP when compared with OVX ADX rats. This re-
sponse may contribute to the attenuation of sodium appetite because
ANP has been postulated to have an inhibitory role on sodium appetite.
Antunes-Rodrigues et al. (1986) demonstrated that the injection of ANP
in the anterior ventral third ventricle region (AV3V) dramatically re-
duces hypertonic saline intake in sodium-depleted rats. Experimental
evidence indicated an abundance of ANP receptors in the SFO, and
this peptide may modulate the excitatory effects of ANG II in SFO neu-
rons, antagonizing its effects, especially related to ingestive behavior
(Ferguson and Bains, 1996). OVX E2 ADX rats showed a greater circulat-
ing volume compared to OVX ADX rats as indicated by a reduction in
hematocrit values, which may contribute in part to increased levels of
circulating ANP observed in these rats. In addition, studies showed
that chronic treatmentwith E2 in OVX rats increases plasma concentra-
tion of ANP (Xu et al., 2008), and this effect is modulated by type α E2
receptors (ER-α) present in cardiac atrium (Jankowski et al., 2001).
Pretreatment with E2 attenuated natriuresis induced by adrenal
insufﬁciency despite attenuated plasma levels of ANG II, increased levels
of ANP and reduced hematocrit values. However, Winaver et al. (1995)
reported that rats with congestive heart failure had reduced urinary
sodium excretion although they had elevated ANP plasma levels, dem-
onstrating a hyporesponsiveness of the kidney to ANP. Blocking angio-
tensin converting enzyme (ACE) induced a signiﬁcant increase in
urinary sodium excretion in these animals, showing an ANG II function-
al antagonism to ANP-induced natriuresis and diuresis. Other investiga-
tors have postulated that ANG IImay prevent ANP natriuretic action due
to a decrease of cellular ANP signaling. ANG II increases phosphodiester-
ase activity, which leads to GMPc (ANP secondmessenger) degradation
(Smith and Lincoln, 1987;Wilkins andNeedleman, 1992;Winaver et al.,
Fig. 7. Effect of pretreatmentwith estradiol on the relative expression of CRF mRNA in the
PVN (A) and on the plasma levels of corticosterone (B) in OVX rats submitted to adrenal-
ectomy with or without replacement with CORT and CORT treatment in rats with intact
adrenal glands. The values are expressed as means ± SEM. +p b 0.05 vs. respective OVX
SHAM group, #p b 0.05 vs. respective OVX SHAM B group, Ψp b 0.05 vs. respective OVX
ADX group, *p b 0.05 vs. respective OVX oil group. The sample size (n) is represented
inside the columns.
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may prevent the natriuretic action of ANP (despite the high plasma
levels of this peptide) and contribute in part to the antinatriuresis ob-
served in these animals. Moreover, some studies have demonstrated
that the E2 antinatriuretic effect may be due to its direct effect
on renal tubules by increasing sodium reabsorption (Brunette and
Leclerc, 2001), as well due to increase of AT1 receptor expression in
the mesangial cells of the renal glomerulus, contributing to the reduc-
tion of the coefﬁcient of glomerular ﬁltration rate (Baiardi et al., 2005).
CORT replacement in OVX ADX rats did not reverse the sodium
appetite induced by ADX. This response may be due to the activity of
the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) in
the kidneys, which can convert the administered CORT in its inactive
metabolite, 11-dehydrocorticosterone (Edwards et al., 1998). In fact, re-
placement with CORT in OVX ADX rats also did not reverse increased
ADX-induced natriuresis. In addition, McEwen et al. (1986) demon-
strated that the replacement with aldosterone in ADX animals results
in reversion of the sodium appetite ADX-induced. Also, the pharmaco-
logical inhibition of 11β-HSD attenuated natriuresis ADX-induced in
ADX replacement with CORT rats (Bailey et al., 2001). Furthermore, it
is known that CORT interacts with MR receptors in the CNS such as
the central amygdala, which induces sodium appetite in rats (Zhang
et al., 1993). In this context, it was observed that treatment with CORT
in ratswith intact adrenal glandswas shown to induce an increase in so-
dium appetite, without affecting natriuresis or plasma ANG II levels,
suggesting being due to CORT central action. Thus, this central effect
of CORT may also contribute to the observed elevated sodium appetite
in OVX ADX B rats. In addition, CORT acts in synergy with ANG II in
the CNS (Epstein, 1992).
CORT replacement in OVX ADX rats attenuates the ADX-induced
high increase in plasma concentration of ANG II, demonstrating a direct
peripheral effect of CORT on the renin angiotensin system (RAS)activity. Whereas AT1 mRNA expression in the SFO was not altered by
adrenalectomy or CORT replacement in OVX rats treated with oil. AT1
receptors in the SFO have been postulated to mediate the HPA axis
response stimulated by circulating ANG II (Jezova et al., 1998; Krause
et al., 2008); therefore, we suggest that the decrease in ANG II plasma
levels induced by CORT replacement in OVXADX ratsmay be associated
with a reduction of CRF mRNA expression in the PVN. Furthermore,
angiotensinergic activation at SFO has been implicated in the central
regulation of blood pressure (Hendel and Collister, 2004; Smith and
Ferguson, 2010). Thus, the regulatory effect of CORT replacement in
OVX ADX rats on peripheral ANG II is of physiological importance in
the regulation of blood pressure. However, more studies are needed to
better elucidate the mechanism by which CORT attenuates plasma
levels of ANG II and its physiological relevance.
AVP plasma levels were not affected by the treatments performed in
this study, demonstrating the absence of their involvement in the
homeostatic responses observed. Also, no changes in plasma sodium
were observed, indicating that the animals were able to restore their
plasma sodium concentration despite the large sodium urinary loss,
which was expected because hypertonic saline solution was offered to
these animals. It is well established that AVP is secreted in response to
hyperosmolality and hypovolemia, being more sensitive to stimuli
that alter plasma osmolality (Haanwinckel et al., 1995). Thus, mainte-
nance of plasma sodium and plasma osmolality correlates with the
absence of changes in AVP secretion under these experimental
conditions. The OT secretion also was not affected by most treatments,
very probably by same explication as for AVP secretion since these
hormones presented the equal secretion stimulus (Godino et al., 2007;
Haanwinckel et al., 1995). Nevertheless the pretreatmentwith E2 atten-
uated plasma OT level in ADX B rats, demonstrating a speciﬁc effect of
E2 associated with CORT in the OT secretion.
Pretreatment with E2 also attenuated the elevated natriuresis re-
sponse observed in ADX B rats. This effect is most likely due to elevated
plasma concentration of ANG II and low plasma ANP and OT in addition
to the other antinatriuretic effects of E2 discussed above. Additionally,
OVXE2ADXB rats showed a signiﬁcant increase inwater intake, revers-
ing the effect induced by ADX. Treatment with E2 or replacement with
CORT alone is not able to prevent the reduction of water intake induced
by ADX. Thus, this study demonstrates for ﬁrst time that it is only when
the two treatments (E2 and CORT) are combined that the reversion
effect induced by ADX on water intake occurs. Increased plasma levels
of ANG II and decreased ANP may contribute to increased water intake
observed in these animals, speciﬁcally considering the dipsogenic effect
of ANG II and the antidipsogenic effect of ANP mentioned above.
Recently, it has been postulated that dipsogenic and natriorexigenic
responses induced by ANG II andmediated by the AT1 receptor are ulti-
mately due to the activation of distinct intracellular signaling pathways.
Daniels et al. (2005, 2007, 2009) showed that water intake involves the
activation of protein kinase C (PKC); nevertheless, the activation ofMAP
kinase plays a role in sodium intake induced by ANG II. Additionally, a
growing number of studies have shown selective binding and activation
of PKC conventional isoforms by steroid hormones. Aldosterone, E2 and
ANG II (via AT1 receptor) activate the same conventional protein kinase
C isoform (PKCα; Alzamora and Harvey, 2008; Sumners et al., 2002). In
this context, it is reasonable to postulate that in response to ADX and in
the presence of CORT and E2, possible crosstalk between E2 and the
CORT cell signaling pathway may occur, which induces higher activa-
tion of PKC in CNS structures involved with the dipsogenic response of
ANG II, such as the SFO. Similarly, potential crosstalk between these
steroid hormones may induce the increase of plasma ANG II and the
reduction of plasma ANP and OT levels in response to ADX.
Pretreatment with E2 inhibited the stimulatory effect on sodium
appetite induced by treatment with CORT in rats with intact adrenal
glands and attenuated urinary sodium excretion. These data demon-
strate that E2 modulates homeostatic responses induced by the
administration of CORT in rats with intact adrenals. E2 may inhibit
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receptor expression or signaling in CNS structures involved in this be-
havior. Some studies have shown that E2 signiﬁcantly reduces mRNA
expression of MR in CNS structures such as the hippocampus, the hypo-
thalamic preoptic area and the adenohypophysis (Burgess and Handa,
1993). Furthermore, no signiﬁcant change in AT1 mRNA expression in
the SFO of the OVX E2 SHAM B rats was observed when compared
with the OVX SHAM B group, supporting the hypothesis that E2 may
inhibit sodium appetite through potential CNS modulation of MR.
We also observed that pretreatment with E2 induced a signiﬁcant
increase in plasma CORT levels in OVX E2 SHAM and OVX E2 SHAM B
rats. E2 also increased the weight of the adrenal glands (data not
shown). These results corroborate data reporting the role of E2 on in-
creased plasma CORT levels and an increase of the weight of adrenal
glands in both OVX rats and proestrus female rats (Ochedalski et al.,
2007; Viau and Meaney, 1991). However, this E2-induced increase in
CORT plasma levels was not accompanied by an increase in CRF mRNA
expression in the PVN. Therefore, the increase in plasma CORT may be
due to a direct effect of E2 on the adrenal gland by stimulating the syn-
thesis of glucocorticoids without altering the basal activity of the HPA
axis. In fact, in vitro studies demonstrated that E2 increases the basal
synthesis of CORT by adrenocortical cells (Nowak et al., 1995) and
in vivo studies showed that E2 enhances adrenal sensitivity to ACTH
in response to stress (Figueiredo et al., 2007).
Additionally, OVX E2 ADX B rats have higher CRFmRNA levels in the
PVN compared with OVX ADX B rats. These data demonstrate that E2
alters the CORT negative feedback signal in neurons of PVN in ADX
rats. Zhang et al. (2009) have shown that E2 reduces ligand-induced
glucocorticoid receptor (GR) phosphorylation and inhibits glucocorti-
coid induction of the mitogen-activated protein kinase phosphatase-1
(MKP-1) and serum/glucocorticoid-regulated kinase genes. In accor-
dance with this study, it is reasonable to suggest that E2 may alter the
CORT negative feedback signal in neurons of PVN through changes in
glucocorticoid binding and GR signaling pathway.
Pretreatment with E2 attenuated the increase of CRF mRNA
expression in the PVN in response to adrenal insufﬁciency, indicating
a reduction of responsiveness of neuron producers of CRF in the PVN
activity modulated by E2. This result is in accordance with reports in
the literature showing that in response to various stressful stimuli, E2
reduces the responsiveness of the HPA axis activity, decreasing the
secretion of ACTH and CRF mRNA expression in the PVN (Figueiredo
et al., 2007; Gerrits et al., 2005; Ochedalski et al., 2007; Redei et al.,
1994). The reduction in AT1 mRNA expression in the SFO induced by
E2 in response to ADX may contribute in part to the attenuation of
CRF mRNA expression in the PVN because the AT1 receptor has been
postulated to mediate the response of HPA axis stimulated by circulat-
ing ANG II via SFO as discussed above.
The effect of E2 in attenuating the responsiveness of neuron pro-
ducers of CRF in the PVN activity after ADX has important relevance
for females, which protects against the physiological changes known
to be induced by increased HPA axis activity. The E2 may attenuate
CRF mRNA expression in the PVN through OT parvocell stimulation
(Dellovade et al., 1999) since these has been recently suggested tomod-
ulate the expression of CRF in a negativemanner (Bülbül et al., 2011). In
this context, Ochedalski et al. (2007) showed that icv administration of
OT reduced CRF mRNA expression in the PVN in OVX rats treated with
E2 on basal and stress-induced restraint conditions. This effect of E2
probably is due to ER-β because its activation in the PVN induced a
reduction of stress-responsive corticosterone and ACTH secretion in
gonadectomized rats (Lund et al., 2006). Moreover many fewer CRH
neurons of the PVN express ER-β whereas a large number of ER-β
immunoreactive cells in PVN are OT positive (Handa et al., 2011)
supporting the hypothesis that E2may attenuate CRFmRNA expression
in the PVN through modulation of OT parvocells.
In conclusion, this study indicates that E2 plays an important role in
modulating behavioral and neuroendocrine responses involved withthe maintenance of hydroelectrolytic homeostasis in response to ADX.
Similarly, E2 decreases the responsiveness of neuron producers of CRF
in the PVN activity under adrenal insufﬁciency condition. The results
also show that E2 modulates the sodium appetite effect induced by
treatment with CORT in rats with intact adrenal glands. However, E2
in the presence of CORT reverses the reduction in water intake induced
by ADX, changes hormonal responses induced by ADX and alters the
negative feedback exerted by CORT in neurons of PVN in ADX condi-
tions. The exact mechanism by which E2 modulates all these responses
deserves further investigation.
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